Quantitative Structure-Activity Relationship Modeling of Pea Protein-Derived Acetylcholinesterase and Butyrylcholinesterase Inhibitory Peptides
- PMID: 37856319
- DOI: 10.1021/acs.jafc.3c04880
Quantitative Structure-Activity Relationship Modeling of Pea Protein-Derived Acetylcholinesterase and Butyrylcholinesterase Inhibitory Peptides
Abstract
The aim of this work was to determine the structural requirements for peptides that inhibit acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) activities. The data set used consisted of 19 oligopeptides that had been identified through mass spectrometry analysis of enzymatic digests of yellow field pea protein. The structure-function relationship was analyzed by partial least squares regression using the 5z scores. A nine-component model was created from 16 peptides for AChE inhibitory peptides (Q2 = 67.2% and R2 = 0.9974), while three data sets were prepared for BuChE inhibitory peptides to improve the quality of the models (Q2 = 26.7-46.4% and R2 = 0.9577-0.9958). The most active peptides from the PLS models have threonine, leucine, alanine, and valine at the N terminal, asparagine, histidine, proline, and arginine at the second position, with aspartic acid and serine at the third, and arginine at the C terminal.
Keywords: Alzheimer’s disease; acetylcholinesterase; butyrylcholinesterase; enzyme inhibition; partial least squares regression; peptides.
Similar articles
-
Acetylcholinesterase and butyrylcholinesterase inhibitory activities of antioxidant peptides obtained from enzymatic pea protein hydrolysates and their ultrafiltration peptide fractions.J Food Biochem. 2022 Nov;46(11):e14289. doi: 10.1111/jfbc.14289. Epub 2022 Jun 27. J Food Biochem. 2022. PMID: 35758753
-
In silico modeling for dual inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) enzymes in Alzheimer's disease.Comput Biol Chem. 2020 Oct;88:107355. doi: 10.1016/j.compbiolchem.2020.107355. Epub 2020 Aug 5. Comput Biol Chem. 2020. PMID: 32801088
-
Evaluation of Novel Dual Acetyl- and Butyrylcholinesterase Inhibitors as Potential Anti-Alzheimer's Disease Agents Using Pharmacophore, 3D-QSAR, and Molecular Docking Approaches.Molecules. 2017 Jul 26;22(8):1254. doi: 10.3390/molecules22081254. Molecules. 2017. PMID: 28933746 Free PMC article.
-
Combined QSAR, molecular docking and molecular dynamics study on new Acetylcholinesterase and Butyrylcholinesterase inhibitors.Comput Biol Chem. 2018 Jun;74:304-326. doi: 10.1016/j.compbiolchem.2018.03.021. Epub 2018 Mar 29. Comput Biol Chem. 2018. PMID: 29747032
-
A Multi-layered Variable Selection Strategy for QSAR Modeling of Butyrylcholinesterase Inhibitors.Curr Top Med Chem. 2020;20(18):1601-1627. doi: 10.2174/1568026620666200616142753. Curr Top Med Chem. 2020. PMID: 32543359
Cited by
-
Preparation of Acetylcholinesterase Inhibitory Peptides from Yellowfin Tuna Pancreas Using Moderate Ultrasound-Assisted Enzymatic Hydrolysis.Mar Drugs. 2025 Feb 9;23(2):75. doi: 10.3390/md23020075. Mar Drugs. 2025. PMID: 39997199 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical